CA Juttner

2.9k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

CA Juttner is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, CA Juttner has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in CA Juttner's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (8 papers) and Immune cells in cancer (8 papers). CA Juttner is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (8 papers) and Immune cells in cancer (8 papers). CA Juttner collaborates with scholars based in Australia, United Kingdom and United States. CA Juttner's co-authors include DN Haylock, PJ Simmons, L. Bik To, LB To, Richard Kimber, LK Ashman, RJ Levinsky, P. Dyson, Sarah Moore and Angel F. López and has published in prestigious journals such as Blood, British Journal of Cancer and Stem Cells.

In The Last Decade

CA Juttner

28 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Biology and Clinical Uses of Blood Stem Cells

1997 582 citations L. Bik To, DN Haylock et al. Blood profile →

Peers

Countries citing papers authored by CA Juttner

Since Specialization

Citations

This map shows the geographic impact of CA Juttner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Juttner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Juttner more than expected).

Fields of papers citing papers by CA Juttner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CA Juttner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Juttner. The network helps show where CA Juttner may publish in the future.

Co-authorship network of co-authors of CA Juttner

This figure shows the co-authorship network connecting the top 25 collaborators of CA Juttner. A scholar is included among the top collaborators of CA Juttner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CA Juttner. CA Juttner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Biology and Clinical Uses of Blood Stem Cells breakdown → 1997 ·Blood ·L. Bik To, DN Haylock, PJ Simmons, CA Juttner	582
2	Standardization of the CFU-GM Assay Using Hematopoietic Growth Factors 1996 ·Journal of Hematotherapy ·Ian D. Lewis, (unknown), P. Dyson, DN Haylock, CA Juttner, L. Bik To	29
3	Ex Vivo Hematopoietic Progenitor Cell Expansion 1994 ·PubMed ·David N. Haylock, Shigeyoshi Makino, (unknown), (unknown), Silvana Niutta, L.B. To, CA Juttner, Paul J. Simmons	9
4	A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells 1994 ·Blood ·LB To, DN Haylock, (unknown), PJ Simmons, (unknown), LK Ashman, CA Juttner	8
5	A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells 1994 ·Blood ·LB To, DN Haylock, (unknown), PJ Simmons, (unknown), LK Ashman, CA Juttner	170
6	G-CSF Mobilised Progenitor Cells in Autologous Transplantation 1992 ·Journal of Nutritional Science and Vitaminology ·C. Glenn Begley, (unknown), Philip A. Rowlings, Jeff Szer, (unknown), CA Juttner, George Morstyn, R. M. Fox, (unknown)	1
7	Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage 1992 ·Blood ·DN Haylock, LB To, (unknown), CA Juttner, PJ Simmons	240
8	Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage 1992 ·Blood ·DN Haylock, LB To, (unknown), CA Juttner, PJ Simmons	297
9	Autologous PBSC transplantation in stage 3 and 4 ovarian cancer 1992 ·Stem Cells ·CA Juttner, Margaret Davy, L. Bik To, DN Haylock, P. Dyson, (unknown), Joanne Bayly	5
10	GM‐CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes* 1991 ·Australian and New Zealand Journal of Medicine ·K Atkinson, Ken Bradstock, J. C. Biggs, Ray M. Lowenthal, K Downs, B.M. Dale, CA Juttner, Jeff Szer	30
11	Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow 1991 ·Blood ·LK Ashman, (unknown), LB To, RJ Levinsky, CA Juttner	165
12	Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow 1991 ·Blood ·LK Ashman, (unknown), LB To, RJ Levinsky, CA Juttner	13
13	Approaches to blood stem cell mobilisation. Initial Australian clinical results. 1990 ·PubMed ·CA Juttner, Lim To, DN Haylock, P. Dyson, K. F. Bradstock, B.M. Dale, Arno Enno, Robert Sage, Jeff Szer, Ian Toogood	13
14	Peripheral blood stem cell selection, collection and auto-transplantation. 1990 ·PubMed ·CA Juttner, L. Bik To, David N. Haylock, P. Dyson	16
15	Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid series 1988 ·Blood ·Angel F. López, P. Dyson, To Lb, MJ Elliott, (unknown), JA Russell, CA Juttner, YC Yang, SC Clark, MA Vadas	84
16	Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid series 1988 ·Blood ·Angel F. López, P. Dyson, LB To, MJ Elliott, (unknown), JA Russell, CA Juttner, (unknown), SC Clark, MA Vadas	9
17	TRANSPLANTATION OF MONOCLONAL ANTIBODY‐PURGED AUTOLOGOUS BONE MARROW FOR TREATMENT OF POOR RISK COMMON ACUTE LYMPHOBLASTIC LEUKEMIA 1987 ·Australian and New Zealand Journal of Medicine ·Kenneth F. Bradstock, Mary Bergin, (unknown), A. Kabral, CA Juttner, Michael Stevens, Luciano Dalla‐Pozza, Emmanuel J. Favaloro, (unknown), Heddy Zola	7
18	High levels of circulating haemopoietic stem cells in very early remission from acute non‐lymphoblastic leukaemia and their collection and cryopreservation 1984 ·British Journal of Haematology ·L. Bik To, DN Haylock, Richard Kimber, CA Juttner	149
19	The effect of monocytes in the peripheral blood CFU-C assay system 1983 ·Blood ·LB To, DN Haylock, CA Juttner, (unknown)	25
20	The effect of monocytes in the peripheral blood CFU-C assay system 1983 ·Blood ·LB To, DN Haylock, CA Juttner, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact